FrancophonIA/ELRC3.0 huggingface dataset:
English: n/a n/a
Croatian: n/a n/d
English: Uncommon (may affect up to 1 in 100 people) • Hyperactivity (high level of activity, restlessness)
Croatian: Manje često (mogu se javiti u do 1 na 100 ljudi) - Hiperaktivnost (visoka razina aktivnosti, nemir)
English: Nimvastid orodispersible tablets are fragile.
Croatian: Nimvastid raspadljive tablete za usta su lomljive.
English: No adverse effects of rivastigmine were observed on fertility or reproductive performance in rats (see section 5.3).
Croatian: Nisu zabilježeni štetni učinci rivastigmina na plodnost ili reproduktivna svojstva štakora (vidjeti dio 5.3).
English: Efficacy has been established by the use of two independent scales which were assessed at regular intervals during a 6-month treatment period as shown in Table 5 below: the ADAS-Cog, a measure of cognition, and the global measure ADCS-CGIC (Alzheimer's Disease Cooperative StudyClinician's Global Impression of Change).
Croatian: Djelotvornost je utvrđena primjenom dvije neovisne ljestvice koje su procjenjivane u redovitim intervalima tijekom razdoblja liječenja od 6 mjeseci kako je prikazano u donjoj Tablici 5: ADAS-Cog, mjerilo kognitivne sposobnosti i globalno mjerilo ADCS-CGIC (eng.
English: Do not use this medicine after the expiry date which is stated on the packaging after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na pakiranju iza „Rok valjanosti“ ili „EXP“.
English: Response Measure
Croatian: Mjerilo odgovora
English: Excipient: sorbitol E420.
Croatian: Pomoćna tvar: sorbitol E420.
English: Biotranformation
Croatian: Biotransformacija
English: ADAS-Cog: improvement of at least 4 points CIBIC-Plus: improvement PDS: improvement of at least 10%
Croatian: ADAS-Cog: poboljšanje od najmanje 4 boda CIBIC-Plus: poboljšanje PDS: poboljšanje od najmanje 10%
English: Rivastigmine orodispersible tablet is bioequivalent to rivastigmine capsules, with a similar rate and extent of absorption.
Croatian: Rivastigmin raspadljiva tableta za usta bioekvivalentna je rivastigmin kapsulama, sa sličnom brzinom i opsegom apsorpcije.
English: ADAS-Cog Rivastigmine
Croatian: ADAS-Cog Rivastigmin
English: Gastrointestinal disorders such as nausea, vomiting and diarrhoea are dose-related, and may occur particularly when initiating treatment and/or increasing the dose (see section 4.8).
Croatian: Gastrointestinalni poremećaji poput mučnine, povraćanja i proljeva ovisni su o dozi te se mogu javiti osobito kod početka liječenja i/ili povećavanja doze (vidjeti dio 4.8).
English: ADCS-CGIC Rivastigmine
Croatian: ADCS-CGIC Rivastigmin
English: Parkinsonism
Croatian: Parkinsonizam
English: As a consequence, rivastigmine has minor or moderate influence on the ability to drive and use machines.
Croatian: Posljedično tome, rivastigmin malo ili umjereno utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: The secondary definition of response required a 4-point or greater improvement on the ADAS-Cog, no worsening on the CIBIC-Plus, and no worsening on the PDS.
Croatian: Za sekundarnu je definiciju odgovora bilo potrebno poboljšanje od 4 boda ili više na ADAS-Cog ljestvici, nikakvo pogoršanje na CIBICPlus ljestvici te nikakvo pogoršanje na PDS ljestvici.
English: If treatment is interrupted for more than three days, it should be re-initiated at 1.5 mg twice daily.
Croatian: Ako se liječenje prekine na više od tri dana, treba ga ponovno početi u dozi od 1,5 mg dva puta dnevno.
English: If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Croatian: Ako Vam je liječnik rekao da ne podnosite neke šećere, obratite mu se prije uzimanja ovog lijeka.
English: Rivastigmine was not mutagenic in a standard battery of in vitro and in vivo tests, except in a chromosomal aberration test in human peripheral lymphocytes at a dose 10
Croatian: U standardnoj bateriji in vitro i in vivo testova, rivastigmin nije bio mutagen, osim u testu kromosomske aberacije na perifernim limfocitima ljudi u dozi koja je bila 10
English: Clinically relevant improvement in these studies was defined a priori as at least 4-point improvement on the ADAS-Cog, improvement on the CIBIC-Plus, or at least a 10% improvement on the PDS.
Croatian: Klinički značajno poboljšanje u ovim ispitivanjima definirano je prvenstveno kao poboljšanje od najmanje 4 boda na ADAS-Cog ljestvici, poboljšanje na CIBIC-Plus ili poboljšanje od najmanje 10% na PDS ljestvici.
English: Nimvastid contains sorbitol E420.
Croatian: Nimvastid sadrži sorbitol E420.
English: No safety margins to human exposure were achieved in the animal studies due to the sensitivity of the animal models used.
Croatian: Zbog osjetljivosti korištenih životinjskih modela, u ispitivanjima na životinjama nisu postignute granice sigurnosti kod izlaganja ljudi lijeku.
English: HDPE container: 200 or 250 hard capsules in a box.
Croatian: HDPE spremnik: 200 ili 250 tvrdih kapsula u kutiji.
English: Based on evidence from animal studies the major cytochrome P450 isoenzymes are minimally involved in rivastigmine metabolism.
Croatian: Na temelju dokaza iz ispitivanja na životinjama, u metabolizam rivastigmina minimalno su uključeni glavni izoenzimi citrokroma P450.
English: Care must be taken when using rivastigmine in patients with sick sinus syndrome or conduction defects (sino-atrial block, atrio-ventricular block) (see section 4.8).
Croatian: Mora se paziti kada se rivastigmin primjenjuje u bolesnika s bolešću sinusnog čvora ili smetnjama provođenja (sinus-atrijski blok, atrioventrikularni blok) (vidjeti dio 4.8).
English: Worsening (including bradykinesia, dyskinesia, gait abnormality) and an increased incidence or severity of tremor have been observed in patients with dementia associated with Parkinson's disease (see section 4.8).
Croatian: Pogoršanje (uključujući bradikineziju, diskineziju, neuobičajeni hod) i povećana incidencija ili težina tremora zapaženi su u bolesnika s demencijom povezanom s Parkinsonovom bolešću (vidjeti dio 4.8).
English: Rivastigmine may cause increased gastric acid secretions.
Croatian: Rivastigmin može uzrokovati povećanu sekreciju želučane kiseline.
English: HDPE container: boxes of 200 or 250 hard capsules are available.
Croatian: HDPE spremnik: dostupne su kutije od 200 ili 250 tvrdih kapsula.
English: Additionally there have been post-marketing cases of dizziness, tremor, headache, somnolence, confusional state, hypertension, hallucinations and malaise.
Croatian: Uz to, nakon stavljanja lijeka u promet bilo je slučajeva omaglice, tremora, glavobolje, somnolencije, stanja konfuzije, hipertenzije, halucinacije i malaksalosti.
English: Nimvastid should not be given at the same time as other medicines with similar effects to Nimvastid.
Croatian: Nimvastid se ne smije davati istodobno s drugim lijekovima sa sličnim djelovanjem Nimvastidu.
English: Caution is advised in patients at higher risk of developing torsade de pointes; for example, those with uncompensated heart failure, recent myocardial infarction, bradyarrhythmias, a predisposition to hypokalaemia or hypomagnesaemia, or concomitant use with medicinal products known to induce QT prolongation and/or torsade de pointes (see sections 4.5 and 4.8).
Croatian: Savjetuje se oprez u bolesnika s visokim rizikom od razvoja torsades de pointes, primjerice, bolesnici s nekompenziranim zatajenjem srca, nedavnim infarktom miokarda, bradiaritmijama, predispozicijom za hipokalijemiju ili hipomagnezijemiju ili bolesnici koji istodobno koriste lijekove za koje je poznato da induciraju produženje QT-intervala i/ili torsades de pointes (vidjeti dijelove 4.5 i 4.8).
English: See leaflet for further information.
Croatian: Vidjeti uputu o lijeku za detaljnije informacije.
English: Caution is recommended in treating patients predisposed to such diseases.
Croatian: Pri liječenju bolesnika koji su predisponirani za takve bolesti, preporučuje se oprez.
English: The recommended maximum daily dose is 6 mg twice a day.
Croatian: Preporučena maksimalna dnevna doza je 6 mg dva puta dnevno.
English: Patients with visual hallucinations
Croatian: Bolesnici s vidnim halucinacijama
English: The use of this medicinal product is contraindicated in patients with known hypersensitivity to the active substance rivastigmine, to other carbamate derivatives or to any of the excipients listed in section 6.1.
Croatian: Primjena ovog lijeka kontraindicirana je u bolesnika s poznatom preosjetljivošću na djelatnu tvarrivastigmin, druge derivate karbamata ili neku od pomoćnih tvari navedenih u dijelu 6.1.
English: Movement disorder Bradykinesia
Croatian: Poremećaj kretanja Bradikinezija
English: Therefore, caution should be exercised when rivastigmine is combined with beta-blockers and also other bradycardia agents (e.g.class III antiarrhythmic agents, calcium channel antagonists, digitalis glycoside, pilocarpin).
Croatian: Stoga je potreban oprez kada se rivastigmin kombinira s beta blokatorima i drugim tvarima za bradikardiju (npr. antiaritmicima skupine III, antagonistima kalcijevih kanala, digitalis glikozidom, pilokarpinom).
English: It has the same dosage and frequency of administration as rivastigmine capsules.
Croatian: Primjenjuje se u istoj dozi i učestalosti kao i rivastigmin kapsule.
English: There have been rare post-marketing reports of patients experiencing allergic dermatitis (disseminated) when administered rivastigmine irrespective of the route of administration (oral, transdermal).
Croatian: Postojala su rijetka iskustva s alergijskim dermatitisom (diseminiranim) u bolesnika nakon stavljanja lijeka u promet kod primjene rivastigmina bez obzira na put primjene (peroralno, transdermalno).
English: Urinary infection
Croatian: Infekcija urinarnog trakta
English: Furthermore, rivastigmine can induce dizziness and somnolence, mainly when initiating treatment or increasing the dose.
Croatian: Nadalje, rivastigmin može dovesti do omaglice i somnolencije, posebice na početku liječenja ili pri povećavanju doze.
English: Pre-defined adverse events that may reflect worsening of parkinsonian symptoms in patients with dementia associated with Parkinson's disease
Croatian: Unaprijed definirani štetni događaji koji mogu odražavati pogoršanje simptoma parkinsonizma u bolesnika s demencijom povezanom s Parkinsonovom bolešću
English: No untoward effects on cardiac conduction were observed following concomitant administration of digoxin and rivastigmine.
Croatian: Nisu zapaženi neželjeni učinci na srčano provođenje nakon istodobne primjene digoksina i rivastigmina.
English: Cholinesterase inhibitors should be prescribed with care to patients with a history of asthma or obstructive pulmonary disease.
Croatian: Inhibitore kolinesteraze treba pažljivo propisivati bolesnicima koji u anamnezi imaju astmu ili opstruktivnu bolest pluća.
English: Cardiac arrhythmia (e.g. bradycardia, atrio-ventricular block, atrial fibrillation and tachycardia) Sick sinus syndrome
Croatian: Aritmija srca (npr. bradikardija, atrioventrikularni blok fibrilacija atrija i tahikardija) Sindrom bolesnog sinusnog čvora
English: The use of rivastigmine in patients with severe dementia of Alzheimer's disease or associated with Parkinson's disease, other types of dementia or other types of memory impairment (e.g. age-related cognitive decline) has not been investigated and therefore use in these patient populations is not recommended.
Croatian: Nije istražena primjena rivastigmina u bolesnika s teškom demencijom Alzheimerove bolesti ili onom povezanom s Parkinsonovom bolešću, drugim vrstama demencije ili drugim vrstama poremećaja pamćenja (npr. smanjenje kognitivne sposobnosti povezane s dobi) te se stoga ne preporučuje primjena u ovoj populaciji bolesnika.
English: The capsules and oral solution can also be used for the treatment of dementia in adult patients with Parkinson's disease.
Croatian: Kapsule i raspadljive tablete za usta također se mogu primjenjivati u liječenju demencije u odraslih bolesnika s Parkinsonovom bolešću.
English: Similarly a larger treatment effect was observed in those patients with visual hallucinations (see Table 6).
Croatian: Slično tome, zapažen je veći učinak liječenja u bolesnika s vidnim halucinacijama (vidjeti Tablicu 6).
English: Possible dose adjustments or temporarily stopping treatment can be considered if needed.
Croatian: Ukoliko je potrebno mogu se razmotriti moguće prilagodbe doze ili privremeni prekid liječenja.
English: Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted with rivastigmine in patients with dementia associated with Parkinson's disease with pre-defined adverse events that may reflect worsening of parkinsonian symptoms.
Croatian: Tablica 3 navodi broj i postotak bolesnika iz specifičnog kliničkog ispitivanja u trajanju od 24 tjedna, provedenog s rivastigminom u bolesnika s demencijom povezanom s Parkinsonovom bolešću, pri čemu su nuspojave, koje bi mogle odražavati pogoršanje simptoma parkinsonizma, bile unaprijed definirane.
English: Clinical studies in dementia associated with Parkinson's disease The efficacy of rivastigmine in dementia associated with Parkinson's disease has been demonstrated in a 24-week multicentre, double-blind, placebo-controlled core study and its 24-week open-label extension phase.
Croatian: Klinička ispitivanja u demenciji povezanoj s Parkinsonovom bolešću Djelotvornost rivastigmina kod demencije povezane s Parkinsonovom bolešću pokazana je u 24tjednom multicentričnom, dvostruko slijepom, placebo kontroliranom, osnovnom ispitivanju te njegovoj 24-tjednoj otvorenoj produženoj fazi.
English: If you are pregnant, the benefits of using Nimvastid must be assessed against the possible effects on your unborn child. Nimvastid should not be used during pregnancy unless clearly necessary.
Croatian: Ako ste trudni, potrebno je ocijeniti koristi od primjene Nimvastida u usporedbi s mogućim učincima na Vaše nerođeno dijete.
English: No evidence of carcinogenicity was found in studies in mice and rats at the maximum tolerated dose, although the exposure to rivastigmine and its metabolites was lower than the human exposure.
Croatian: U ispitivanjima na miševima i štakorima pri maksimalnoj dozi koju su životinje podnosile, nije utvrđen dokaz kancerogenosti, iako je izloženost rivastigminu i njegovim metabolitima bila niža od izloženosti u ljudi.
English: Symptomatic treatment of mild to moderately severe dementia in patients with idiopathic Parkinson's disease.
Croatian: Simptomatsko liječenje blage do umjereno teške demencije u bolesnika s idiopatskom Parkinsonovom bolešću.
English: Other side effects seen with rivastigmine transdermal patches and which may occur with the hard capsules:
Croatian: Ostale nuspojave zabilježene s rivastigmin transdermalnim flasterima a koje se mogu pojaviti s tvrdim kapsulama:
English: Marketing Authorisation Holder and Manufacturer KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Croatian: Nositelj odobrenja za stavljanje lijeka u promet i proizvođač KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija
English: Hallucinations Aggression, restlessness
Croatian: Halucinacije Agresivnost, nemir
English: Hold the blister strip at the edges and separate one blister cell from the rest of the strip by gently tearing along the perforations around it,
Croatian: Primite blister za rubove i razdvojite jedno polje blistera od ostalog dijela, pažljivo trgajući duž perforacija koje ga okružuju.
English: The Cmax of rivastigmine was approximately 60% higher and the AUC of rivastigmine was more than twice as high in subjects with mild to moderate hepatic impairment than in healthy subjects.
Croatian: Cmax rivastigmina bio je oko 60% veći, a AUC rivastigmina bila je više nego dvostruko veća u ispitanika s blagim do umjerenim oštećenjem jetre, nego u zdravih ispitanika.
English: Table 2 shows the adverse reactions reported during clinical studies conducted in patients with dementia associated with Parkinson's disease treated with rivastigmine capsules.
Croatian: Tablica 2 pokazuje nuspojave zabilježene tijekom kliničkih ispitivanja provedenih u bolesnika s demencijom povezanom s Parkinsonovom bolešću liječenih rivastigmin kapsulama.
English: Rivastigmine might interfere with the activity of anticholinergic medicinal products (e.g oxybutynin, tolterodine).
Croatian: Rivastigmin može utjecati na djelovanje antikolinergika (npr. oksibutinina, tolterodina).
English: Rivastigmine should be administered twice a day, with morning and evening meals.
Croatian: Rivastigmin treba primjenjivati dva puta dnevno, uz jutarnji i večernji obrok.
English: Thus, rivastigmine may have an ameliorative effect on cholinergic-mediated cognitive deficits in dementia associated with Alzheimer's disease and Parkinson's disease.
Croatian: Stoga rivastigmin može imati ublažavajuće djelovanje na kolinergički posredovane deficite kognitivne funkcije kod demencije povezane s Alzheimerovom i Parkinsonovom bolešću.
English: Dose titration: Adverse reactions (e.g. hypertension and hallucinations in patients with Alzheimer's dementia and worsening of extrapyramidal symptoms, in particular tremor, in patients with dementia associated with Parkinson's disease) have been observed shortly after dose increase.
Croatian: Titriranje doze: nuspojave (npr. hipertenzija i halucinacije u bolesnika s Alzheimerovom demencijom te pogoršanje ekstrapiramidalnih simptoma, osobito tremora, u bolesnika s demencijom povezanom s Parkinsonovom bolešću) zapažene su ubrzo nakon povećanja doze.
English: Similarly a larger effect was observed in Parkinson's disease patients with visual hallucinations (see section 5.1).
Croatian: Slično tome, zapažen je veći učinak u bolesnika s Parkinsonovom bolešću i s vidnim halucinacijama (vidjeti dio 5.1).
English: Other side effects seen with rivastigmine transdermal patches and which may occur with the orodispersible tablets:
Croatian: Ostale nuspojave zabilježene s rivastigmin transdermalnim flasterima a koje se mogu pojaviti s raspadljivim tabletama za usta:
English: Since bradycardia constitutes a risk factor in the occurrence of torsades de pointes, the combination of rivastigmine with torsades de pointes-inducing medicinal products such as antipsychotics i.e. some phenothiazines (chlorpromazine, levomepromazine), benzamides (sulpiride, sultopride, amisulpride, tiapride, veralipride), pimozide, haloperidol, droperidol, cisapride, citalopram, diphemanil, erythromycin IV, halofantrin, mizolastin, methadone, pentamidine and moxifloxacine should be observed with caution and clinical monitoring (ECG) may also be required.
Croatian: Obzirom da bradikardija predstavlja rizik za pojavu torsades de pointes, kombinacija rivastigmina s lijekovima koji mogu inducirati torsades de pointes kao što su što su antipsihotici npr. neki fenotiazini (klorpromazin, levomepromazin), benzamidi (sulpirid, sultoprid, amisulprid, tiaprid, veralipride), pimozid, haloperidol, droperidol, cisaprid, citalopram, difemanil, eritromicin IV, halofantrin, mizolastin, metadon, pentamidin i moksifloksacin mora se pažljivo pratiti te također može biti potrebno kliničko praćenje (EKG).
English: Cholinergic toxicity has been reported with muscarinic symptoms that are observed with moderate poisonings such as miosis, flushing, digestive disorders including abdominal pain, nausea, vomiting and diarrhoea, bradycardia, bronchospasm and increased bronchial secretions, hyperhidrosis, involuntary urination and/or defecation, lacrimation, hypotension and salivary hypersecretion.
Croatian: Zabilježena je kolinergička toksičnost s muskarinskim simptomima koji su uočeni uz umjereno trovanje kao što su mioza, crvenilo uz osjećaj vrućine, probavni poremećaji uključujući bol u abdomenu, mučninu, povraćanje i proljev, bradikardija, bronhospazam i pojačano izlučivanje bronhijalne sluzi, hiperhidroza, nevoljno mokrenje i/ili defekacija, suzenje očiju, hipotenzija i hipersekrecija sline.
English: • Inflammation of the pancreas - the signs include serious upper stomach pain, often with feeling sick (nausea) or being sick (vomiting)
Croatian: - Upala gušterače - znakovi uključuju jaku bol u gornjem dijelu trbuha, često s osjećajem mučnine ili povraćanjem
English: Cmax and AUC of rivastigmine were more than twice as high in subjects with moderate renal impairment compared with healthy subjects; however there were no changes in Cmax and AUC of rivastigmine in subjects with severe renal impairment.
Croatian: U usporedbi sa zdravim ispitanicima, Cmax i AUC rivastigmina bili su više nego dvostruko veći u ispitanika s umjerenim oštećenjem bubrega; no, u ispitanika s teškim oštećenjem bubrega nije bilo promjena u Cmax i AUC vrijednostima rivastigmina.
English: Nimvastid may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose.
Croatian: Nimvastid može uzrokovati omaglicu i pospanost, pogotovo na početku liječenja ili prilikom povećanja doze.
English: Based on in vitro studies, no pharmacokinetic interaction is expected with medicinal products metabolised by the following cytochromes isoemzymes: CYP1A2, CYP2D6, CYP3A4/5, CYP2E1,
Croatian: Na temelju in vitro ispitivanja, ne očekuje se nikakva farmakokinetička interakcija s lijekovima koji se metaboliziraju sljedećim izoenzimima citokroma: CYP1A2, CYP2D6, CYP3A4/5, CYP2E1,
English: Your mouth should be empty before taking the tablet.
Croatian: Ne smijete imati ništa u ustima prije uzimanja tablete.
English: Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristic, Section 4.2.)
Croatian: Lijek se izdaje na ograničeni recept (vidjeti Dodatak I: Sažetak opisa svojstava lijeka, dio 4.2).
English: The starting dose is 1.5 mg twice a day.
Croatian: Početna doza je 1,5 mg dva puta na dan.
English: Parkinson's disease (worsening) Bradykinesia
Croatian: Parkinsonova bolest (pogoršanje) Bradikinezija
English: Nimvastid 1.5 mg hard capsules Nimvastid 3 mg hard capsules Nimvastid 4.5 mg hard capsules Nimvastid 6 mg hard capsules Rivastigmine
Croatian: Nimvastid 1,5 mg tvrde kapsule Nimvastid 3 mg tvrde kapsule Nimvastid 4,5 mg tvrde kapsule Nimvastid 6 mg tvrde kapsule rivastigmin
English: Date of first authorisation: 11/5/2009 Date of latest renewal: DD month YYYY
Croatian: Datum prvog odobrenja: 11. svibnja 2009.
English: Patients with severe hepatic impairment have not been studied, however, Nimvastid orodispersible tablets may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 5.2).
Croatian: Nisu proučavani bolesnici s teškim oštećenjem jetre, međutim, Nimvastid tablete mogu se primjenjivati u ovoj bolesničkoj populaciji pod uvjetom da se provodi pažljivo praćenje (vidjeti dijelove 4.4 i 5.2).
English: difficulty in carrying out movements and muscle weakness
Croatian: otežanog izvođenja pokreta te slabost mišića
English: Patients with Alzheimer's disease may lose weight.
Croatian: Moguć je gubitak tjelesne težine u bolesnika s Alzheimerovom bolešću.
English: How to store Nimvastid
Croatian: Kako čuvati Nimvastid
English: Patients with severe hepatic impairment have not been studied, however, Nimvastid capsules may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 5.2).
Croatian: Nisu proučavani bolesnici s teškim oštećenjem jetre, međutim, Nimvastid kapsule mogu se primjenjivati u ovoj bolesničkoj populaciji pod uvjetom da se provodi pažljivo praćenje (vidjeti dijelove 4.4 i 5.2).
English: Patients with clinically significant renal or hepatic impairment might experience more adverse reactions (see sections 4.2 and 5.2).
Croatian: U bolesnika s klinički značajnim oštećenjem bubrega ili jetre može se razviti više nuspojava (vidjeti dijelove 4.2 i 5.2).
English: Last Observation Carried Forward
Croatian: Last Observation Carried Forward; zadnje zapažanje prenešeno dalje).
English: Nervous system disorders Very common
Croatian: Poremećaji živčanog sustava Vrlo često